Recurrent Fetal Loss and Antiphospholipid Antibodies
Author Information
Author(s): O. Bl6try, A.-M. Piette
Primary Institution: Service de Médecine Interne, Hôpital Foch, Suresnes, France
Hypothesis
The study investigates the relationship between recurrent fetal loss and antiphospholipid antibodies.
Conclusion
Screening for antiphospholipid antibodies is recommended after multiple fetal losses, as treatment can significantly improve outcomes.
Supporting Evidence
- Recurrent fetal loss affects 1-5% of women of childbearing age.
- Chromosomal abnormalities account for 60% of recurrent fetal loss.
- Immunological mechanisms may account for 40% of recurrent fetal loss, with antiphospholipid syndrome implicated in 7-25% of cases.
- An association of aspirin and heparin given early during gestation is successful in 70-80% of high-risk patients.
Takeaway
If a mom has had three miscarriages, doctors should check for certain antibodies that might be causing the problem, and treating those can help her have a healthy baby.
Methodology
The study involved a review of existing literature and clinical data regarding the association of antiphospholipid antibodies with recurrent fetal loss.
Potential Biases
Potential biases due to interlaboratory variations in antibody testing.
Limitations
The study highlights variability in test results and the need for larger, more standardized studies.
Participant Demographics
Women of childbearing age with a history of recurrent fetal loss.
Want to read the original?
Access the complete publication on the publisher's website